While pantoprazole was not associated with increased risk of reinfarction, the other PPIs were associated with a 40% increase in the risk of reinfarction.
El pantoprazol no se asoció con aumento del riesgo de reinfarto, pero los otros IBP sí, con un 40% de riesgo.